P3 Health Partners (NASDAQ:PIII – Get Free Report) and Bullfrog AI (NASDAQ:BFRG – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
Valuation & Earnings
This table compares P3 Health Partners and Bullfrog AI”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| P3 Health Partners | $1.46 billion | 0.01 | -$147.95 million | ($45.20) | -0.06 |
| Bullfrog AI | $120,000.00 | 112.36 | -$6.50 million | ($0.63) | -1.69 |
Insider and Institutional Ownership
7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 17.8% of P3 Health Partners shares are held by insiders. Comparatively, 25.2% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
P3 Health Partners has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of -2.29, indicating that its stock price is 329% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and price targets for P3 Health Partners and Bullfrog AI, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| P3 Health Partners | 1 | 2 | 1 | 0 | 2.00 |
| Bullfrog AI | 1 | 0 | 0 | 0 | 1.00 |
P3 Health Partners currently has a consensus target price of $3.50, indicating a potential upside of 31.58%. Given P3 Health Partners’ stronger consensus rating and higher possible upside, analysts clearly believe P3 Health Partners is more favorable than Bullfrog AI.
Profitability
This table compares P3 Health Partners and Bullfrog AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| P3 Health Partners | -10.14% | -302.33% | -20.72% |
| Bullfrog AI | N/A | -273.24% | -208.55% |
Summary
P3 Health Partners beats Bullfrog AI on 8 of the 14 factors compared between the two stocks.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
About Bullfrog AI
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
